Name: ELAN Cash Flow - Elanco Animal Health Operating Cash & FCF | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Operating Cash Flow, Investing Cash Flow, Financing Cash Flow, Capital Expenditures, Free Cash Flow, Dividends Paid, Stock Buybacks, Net Change in Cash

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ELAN - Elanco Animal Health Inc.

USD|NYSE|Healthcare

ELAN Cash Flow - Elanco Animal Health Operating Cash & FCF | Ledgeburg

(USD in millions, except per-share data and share counts)	Q2 FY 2630 Jun 2026	Q1 FY 2631 Mar 2026	Q4 FY 2531 Dec 2025	Q3 FY 2530 Sep 2025	Q2 FY 2530 Jun 2025	Q1 FY 2531 Mar 2025	Q4 FY 2431 Dec 2024	Q3 FY 2430 Sep 2024	Q2 FY 2430 Jun 2024	Q1 FY 2431 Mar 2024	Q4 FY 2331 Dec 2023	Q3 FY 2330 Sep 2023	Q2 FY 2330 Jun 2023	Q1 FY 2331 Mar 2023	Q4 FY 2231 Dec 2022	Q3 FY 2230 Sep 2022	Q2 FY 2230 Jun 2022	Q1 FY 2231 Mar 2022	Q4 FY 2131 Dec 2021	Q3 FY 2130 Sep 2021	Q2 FY 2130 Jun 2021	Q1 FY 2131 Mar 2021	Q4 FY 2031 Dec 2020	Q3 FY 2030 Sep 2020	Q2 FY 2030 Jun 2020	Q1 FY 2031 Mar 2020	Q4 FY 1931 Dec 2019	Q3 FY 1930 Sep 2019	Q2 FY 1930 Jun 2019	Q1 FY 1931 Mar 2019	Q4 FY 1831 Dec 2018	Q3 FY 1830 Sep 2018	Q2 FY 1830 Jun 2018	Q1 FY 1831 Mar 2018	Q3 FY 1730 Sep 2017
Net Income
Net Income	54.0	57.0	(276.0)	(34.0)	11.0	67.0	(8.0)	364.0	(50.0)	32.0	(141.0)	(1,096.0)	(97.0)	103.0	(54.0)	(65.0)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Most recent period as filed 5 August 2026, reported in USD. Period end dates link to the filing on SEC EDGAR.

(USD in millions, except per-share data and share counts)	TTM30 Jun 2026	FY202531 Dec 2025	FY202431 Dec 2024	FY202331 Dec 2023	FY202231 Dec 2022	FY202131 Dec 2021	FY202031 Dec 2020	FY201931 Dec 2019	FY201831 Dec 2018	FY201731 Dec 2017	FY201631 Dec 2016
Net Income
Net Income	(199.0)	(232.0)	338.0	(1,231.0)	(78.0)	(483.0)	(574.0)	68.0	86.5	(310.7)	(47.9)
Cash From Operating Activities
Depreciation & Amortization

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Most recent period as filed 24 February 2026, reported in USD. Period end dates link to the filing on SEC EDGAR.

Cash From Operating Activities
Depreciation & Amortization	26.0	172.0	466.0	28.0	25.0	161.0	447.0	27.0	22.0	166.0	-	-	-	173.0	-	-	-	176.0	-	-	-	202.0	-	-	-	82.0	-	-	-	75.2	-	-	-	74.3	-
Amortization Of Intangibles	139.0	138.0	139.0	140.0	136.0	128.0	130.0	133.0	131.0	133.0	138.0	140.0	136.0	134.0	130.0	128.0
Stock-Based Compensation	-	21.0	-	-	-	15.0	-	-	-	11.0	-	-	-	12.0	-	-	-
Deffered Income Tax	-	-	-	-	-	-	-	-	-	-	-	-	-	2.0	-	-	-	(7.0)
Asset Impairments	-	-	-	-	-	-	-	0.0	-	-	-	1,042.0	-	-	-	0.0	-	-
Gains & Losses On Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change In Accounts Receivable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change In Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change In Accounts Payable	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change In Other Working Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Activities	-	21.0	-	-	-	(10.0)	-	-	-	(30.0)	-	-	-	6.0	-	-	-
Cash From Operating Activities	-	13.0	-	-	-	(4.0)	-	-	-	2.0	-	-	-	(145.0)	-

Cash From Investing Activities
Capital Expenditures	-	51.0	-	-	-	65.0	-	-	-	24.0	-	-	-	24.0	-	-	-	19.0	-	-	-	18.0	-	-	-	13.0	-	-	-	28.0	-	-	-	32.7	-
Acquisitions	-	-	-	-	-	-	-	-	-	5.0	-	-	-	16.0	-	-	-	0.0
Divestitures	-	0.0	-	-	-	9.0	-	-	-	66.0	-	-	-	-	-	-	-	-
Purchase Of Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Sales Of Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing Activities	-	9.0	-	-	-	2.0	-	-	-	5.0	-	-	-	1.0	-	-	-
Cash From Investing Activities	-	(60.0)	-	-	-	(58.0)	-	-	-	37.0	-	-	-	(55.0)	-

Cash From Financing Activities
Debt Issued	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Debt Repaid	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Stock Issuance	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Stock Repurchased	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Financing Activities	-	(15.0)	-	-	-	(7.0)	-	-	-	(14.0)	-	-	-	(7.0)	-	-	-
Cash From Financing Activities	-	(65.0)	-	-	-	52.0	-	-	-	(27.0)	-	-	-	174.0	-

Change In Cash & Equivalents
Effects Of Exchange Rate Changes	-	(5.0)	-	-	-	29.0	-	-	-	(19.0)	-	-	-	(1.0)	-	-	-	(5.0)	-	-	-	(25.0)	-	-	-	(9.0)	-	-	-	(14.5)	-	-	-	3.9	-
Net Change In Cash	-	(117.0)	-	-	-	19.0	-	-	-	(7.0)	-	-	-	(27.0)	-	-	-	(296.0)
Cash Beginning Of Period	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash End Of Period	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Free Cash Flow
Free Cash Flow	-	(38.0)	-	-	-	(69.0)	-	-	-	(22.0)	-	-	-	(169.0)	-	-	-	(81.0)	-	-	-	4.0	-	-	-	(9.0)	-	-	-	(19.9)	-	-	-	14.3	-
Free Cash Flow To Equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Cash From Investing Activities
Capital Expenditures	-	276.0	147.0	140.0	171.0	159.0	135.0	140.0	134.5	98.6	110.3
Acquisitions	-	0.0	41.0	19.0	0.0	342.0	5,001.0	33.0	0.0	882.1	45.0
Divestitures	-	9.0	1,360.0	0.0	0.0	-	-	-	-	-	-
Purchase Of Investments	-	-	-	-	-	-	-	-	-	-	-
Sales Of Investments	-	-	-	-	-	-	-	-	-	-	-
Other Investing Activities	-	12.0	14.0	10.0	8.0	(9.0)	(26.0)	5.0	(0.1)	3.0	34.2
Cash From Investing Activities	-	(279.0)	1,158.0	(169.0)	(179.0)	(530.0)	(4,779.0)	(235.0)	(127.0)	(964.6)	(182.1)

Change In Cash & Equivalents
Effects Of Exchange Rate Changes	-	71.0	(91.0)	(12.0)	(17.0)	(31.0)	27.0	(17.0)	29.0	7.9	(26.0)
Net Change In Cash	-	77.0	116.0	7.0	(293.0)	132.0	161.0	(333.0)	354.1	64.6	(201.8)
Cash Beginning Of Period	-	-	-	-	-	-	-	-	-	-	-
Cash End Of Period	-	-	-	-	-	-	-	-	-	-	-

Free Cash Flow
Free Cash Flow	-	284.0	394.0	131.0	281.0	324.0	(176.0)	84.0	352.8	75.2	45.6
Free Cash Flow To Equity	-	-	-	-	-	-	-	-	-	-	-

Cash Flow Statement